Delivery Order SPE2DB20D2104-SPE2DB24FR99U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.32, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 11, 2025 and is not designated as a set-aside. The contract provides for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product, to support federal government...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a ceiling value of $1,549.05 and a performance period ending on May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REYVOW 50 MG TABLET UD 8S. The contract, valued at $2,641.90, is a delivery order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, worth up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities,...
- This federal contract award is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,226.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4564689197 REYVOW 100 MG TABLET UD 8S. The contract has a ceiling value of $1,226.28 and is a Firm Fixed Price Delivery Order that runs through May 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, particularly within military and veterans'...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.31 firm fixed-price delivery order covers the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $3,232.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply REYVOW 100 MG TABLET UD 8S. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 9, 2024. The contract does not have a set-aside designation. AmerisourceBergen, through its corporate office division, has been awarded numerous federal contracts and indefinite delivery...
- This federal contract award, valued at $1,226.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a completion date of August 16, 2024. The contract was awarded on August 15, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and...
- This federal contract award is for the pharmaceutical product REYVOW 50 MG TABLET UD 8S, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,537.34 firm fixed price delivery order has a completion date of November 22, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,090.18 firm-fixed-price delivery order covers the procurement of 4563774504 - REYVOW 100 MG TABLET UD 8S, with a performance period through February 27, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs)...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR99UDelivery Order
This federal contract award is for the delivery of REYVOW 100 MG TABLET UD 8S, a prescription medication, to the Defense Logistics Agency (DLA). The contract, valued at $3,974.21, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance ending on January 11, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00. These IDCs enable Amerisourcebergen to efficiently deliver a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving the Department of Defense and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 1/10/24 |